ted22M to News · 2 days ago

New pancreatic cancer drug doubles survival compared to standard-of-care in late-stage clinical trial - posted by u/NotGenentech

0

cross-posted to:
singularity@lemmit.online

1

New pancreatic cancer drug doubles survival compared to standard-of-care in late-stage clinical trial - posted by u/NotGenentech

ted22M to News · 2 days ago

0

cross-posted to:
singularity@lemmit.online

Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

You must log in or # to comment.

Chat